ask="90.00"
ask_size="100"
average_daily_volume="463106"
bid="73.88"
bid_size="100"
book_value="11.38"
change="+0.06"
change_from_200_day_moving_average="6.32"
change_from_50_day_moving_average="4.30"
change_from_52_week_high="-9.95"
change_From_52_week_low="30.30"
change_in_percent="+0.08%"
close="76.82"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37689000"
high="77.58"
high_52_weeks="86.77"
last_trade_date="2/16/2017"
last_trade_price="76.82"
last_trade_size="47446"
last_trade_time="4:00pm"
low="74.94"
low_52_weeks="46.52"
market_capitalization="3.14B"
moving_average_200_day="70.50"
moving_average_50_day="72.52"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="77.58"
pe_ratio="N/A"
peg_ratio="-0.41"
percent_change_from_200_day_moving_average="+8.96%"
percent_change_from_50_day_moving_average="+5.93%"
percent_change_from_52_week_high="-11.47%"
percent_change_from_52_week_low="+65.13%"
previous_close="76.76"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.74"
price_per_sales="24502.63"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="15.47"
stock_exchange="NMS"
symbol="RARE"
volume="432478"
weeks_range_52="46.52 - 86.77"
